VCBeat Health Contact Us
Home China Healthcare Capital Recognized as Top 50 Value Investment & Service Institution at 2026 Future Healthcare 100 Awards; Portfolio Companies Shine Across Multiple Categories

China Healthcare Capital Recognized as Top 50 Value Investment & Service Institution at 2026 Future Healthcare 100 Awards; Portfolio Companies Shine Across Multiple Categories

May 22, 2026 10:50 CST Updated 10:50
GenFleet Therapeutics

Innovative Drug Developer

MindRank

AI Drug Developer

Haihe Biopharma

Developer of Innovative Anti-Tumor Drugs


May 21,The "2026 Future Healthcare 100 Strong" list, jointly initiated by VCBeat and VB-100, has been officially announced.Huagai Capital HonoredTop 50 Value Investment and Service Institutions in China's Medical and Health IndustryWang Xun, Chief Investment Officer of Huagai Healthcare Fund, HonoredThe 50 Most Influential People in China's Healthcare and Health Industry Innovation.

图片
Huagai Family Honored with the Following Awards:

Top 50 Most Investment-Worthy Enterprises in China's Healthcare Industry

GenFleet Therapeutics (02595.HK),MindRank,HaiHe Biopharma


Top 100 List of Innovative Devices and Intelligent Manufacturing
Shukun Technology, Weimai Medical,KeyMed,Ruilaipu Medical,Lead Innovation MedTech

Top 100 List of Innovative Pharmaceuticals and Biologics
HaiHe Biopharma Co., Ltd,Libang Pharmaceuticals,Eccogene Bio,VaccinogenZhiPeptide Bio,Mainwell Pharmaceuticals,MindRank,Dingchi Bio,Haibo Pharmaceuticals,Sailxin Bio

Top 100 List of Innovative Health Services and Industry Chain Services
GeneplusBaijun Biotech,Giant Tech,MobiDrop Biotech
Image
Image
-End--  
Source Statement: Originated from VCBeat, edited by Huagai Capital. All rights reserved. Copyright Notice: Unless it is impossible to confirm, we have obtained authorization for the articles we publish and have indicated the author and source. If we fail to contact the original author when pushing some articles, and if it involves copyright issues, please contact us in the background, so that we can handle it in time.

Huagai Capital

Huagai Capital was founded in 2012 by a group of professionals from well-known investment institutions inside and outside China. With the vision of "becoming the most trusted capital partner for entrepreneurs and investors," the company focuses on the two major fields of healthcare and technology, and is committed to promoting the growth of small and medium-sized enterprises into industry leaders. Currently, the company manages assets exceeding 30 billion RMB, and 32 of its portfolio companies have successfully gone public.